On the occasion of the talks between the EU, South Africa, India and the USA on a compromise to waive intellectual property rights for coronavirus products, the biotechnology industry association BIO Deutschland reiterates the importance of patent protection for the success story of innovative vaccines.
On 22 March, Oliver Schacht, Chairman of the Board of BIO Deutschland participated in a panel discussion titled “Biotechnology in Germany – Top in the World?”, on which he was joined by Prof. Martina Schraudner, of TU Berlin and Director of the Fraunhofer Center for Responsible Research and Innovation (CeRRI); Thomas Jarzombek, a Bundestag member for the CDU; and Karl Bär, a Bundestag member for Alliance '90/The Greens.
The Innovative Health Initiative Joint Undertaking (IHI JU) held its launch event in March. IHI seeks to build on the successes of and lessons learned from the Innovative Medicine Initiative (IMI).
New video “Biotechnology in Germany” produced in cooperation with the Health – Made in Germany export initiative
The Health – Made in Germany export initiative, in which BIO Deutschland has been an active member of the Medical Biotechnology Working Group for many years, has updated its promotional video on the German biotechnology sector.
In mid-March, the experts on ISO/TC 276 Biotechnology convened for this year’s plenary session and to discuss the work of the various working groups. The chairs of the working groups reported on the progress of standardisation work in their respective groups.